MLAB Financials

Income Statement
MetricQ1 2027Q4 2026Q3 2026Q2 2026Q1 2026
Revenue
60.1M
-5.6%
63.7M
-2.2%
65.1M
+7.2%
60.7M
+2.0%
59.5M
Cost of Revenue
21.1M
-1.8%
21.5M
-7.8%
23.3M
-0.3%
23.4M
+3.5%
22.6M
Gross Profit
39.0M
-7.6%
42.2M
+1.0%
41.8M
+12.0%
37.3M
+1.1%
36.9M
Operating Expenses
32.0M
-18.9%
39.5M
+16.7%
33.8M
+3.7%
32.6M
-3.7%
33.9M
R&D
4.7M
-9.9%
5.2M
+4.3%
5.0M
-0.4%
5.0M
+1.3%
5.0M
SG&A
27.3M
-20.3%
34.2M
+18.8%
28.8M
+4.5%
27.6M
-4.6%
28.9M
Operating Income
7.0M
+155.9%
2.7M
-65.5%
8.0M
+68.8%
4.7M
+54.2%
3.1M
EBITDA
12.7M
+49.2%
8.5M
-37.9%
13.7M
+29.5%
10.6M
+17.2%
9.0M
Net Income
2.8M
+168.4%
-4136000
-213.9%
3.6M
+46.6%
2.5M
-47.8%
4.7M
EPS (Basic)
$0.50
+166.7%
$-0.75
-213.6%
$0.66
+46.7%
$0.45
-48.3%
$0.87
EPS (Diluted)
$0.49
+166.2%
$-0.74
-213.8%
$0.65
+44.4%
$0.45
-47.1%
$0.85
Shares (Diluted)
5.8M
+2.7%
5.6M
+0.8%
5.6M
+0.5%
5.5M
-0.3%
5.6M
Mesa Laboratories (MLAB) โ€” Financials